Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Valsartan in Elderly Isolated Systolic Hypertension.

Trial Profile

Valsartan in Elderly Isolated Systolic Hypertension.

Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Valsartan (Primary)
  • Indications Isolated systolic hypertension
  • Focus Therapeutic Use
  • Acronyms VALISH
  • Most Recent Events

    • 22 Jun 2010 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
    • 22 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jun 2010 Results published in Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top